Amalgamated Bank Raises Stock Position in Doximity, Inc. (NASDAQ:DOCS)

Amalgamated Bank raised its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 2.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 60,742 shares of the company’s stock after acquiring an additional 1,343 shares during the quarter. Amalgamated Bank’s holdings in Doximity were worth $3,243,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the business. FMR LLC grew its position in shares of Doximity by 30.5% during the third quarter. FMR LLC now owns 6,837,733 shares of the company’s stock worth $297,920,000 after purchasing an additional 1,598,602 shares in the last quarter. State Street Corp boosted its stake in Doximity by 2.5% in the 3rd quarter. State Street Corp now owns 3,693,982 shares of the company’s stock worth $160,947,000 after purchasing an additional 88,922 shares during the period. Geode Capital Management LLC grew its holdings in Doximity by 19.8% during the 3rd quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock valued at $124,503,000 after buying an additional 472,565 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Doximity by 4.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 753,001 shares of the company’s stock valued at $32,808,000 after buying an additional 31,966 shares during the last quarter. Finally, Lord Abbett & CO. LLC purchased a new position in shares of Doximity in the third quarter worth $29,453,000. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

DOCS has been the subject of several research analyst reports. Stephens initiated coverage on shares of Doximity in a research note on Friday, December 20th. They set an “equal weight” rating and a $55.00 target price for the company. Leerink Partners upgraded Doximity from a “market perform” rating to an “outperform” rating and raised their price objective for the company from $60.00 to $90.00 in a research report on Friday, February 7th. Bank of America boosted their target price on Doximity from $54.00 to $57.00 and gave the stock a “neutral” rating in a research report on Monday, January 6th. Needham & Company LLC raised their price target on Doximity from $65.00 to $82.00 and gave the company a “buy” rating in a report on Friday, February 7th. Finally, Morgan Stanley raised Doximity from an “underweight” rating to an “equal weight” rating and lifted their price objective for the stock from $33.00 to $53.00 in a research note on Thursday, November 14th. Eleven research analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $64.22.

Insider Buying and Selling

In other news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 37.40% of the stock is owned by corporate insiders.

Doximity Price Performance

Shares of NASDAQ:DOCS opened at $70.44 on Friday. The firm has a market capitalization of $13.15 billion, a PE ratio of 70.44, a price-to-earnings-growth ratio of 4.10 and a beta of 1.39. The business has a 50 day simple moving average of $61.91 and a two-hundred day simple moving average of $50.61. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $85.21.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.